medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2010, Number 6

<< Back Next >>

Rev Mex Urol 2010; 70 (6)

Manejo de la vejiga neurogénica en un hospital pediátrico de México

Moussali-Flah L, Cohen-Cohen S, Gómez-Peña F, Gómez-Peña G, Mosqueira-Mondragón C, Landa-García R

Language: Spanish
References: 23
Page: 364-369
PDF size: 1826.02 Kb.


ABSTRACT

Objective: To analyze management and clinical progression of Mexican pediatric patients with neurogenic bladder and urinary incontinence at the Shriners Hospital for Children in Mexico City who underwent Indiana Pouch and Mitrofanoff continent urinary diversion.
Methods: A descriptive, retrospective study was carried out on patients that underwent continent urinary diversion from 1992-2008. Individual medical pathology, surgical technique chosen, and postoperative complications were reviewed from the case records of these patients.
Results: Continent urinary diversion was carried out in one hundred and sixteen patients with mean age of eleven years and with different urinary incontinence base etiologies. Myelomeningocele (n=112) (96.5%) was the most common. Mitrofanoff (n=29) (25%) and Indiana Pouch (n= 87) (75%) surgical procedures were performed. Bladder lithiasis (n=14) (28%) was the most frequent postoperative complication.
Conclusions: The authors are familiar with the Brantley-Scott artificial sphincter but its use in their medical environment is limited due to the high cost involved. Natural valves such as the ileocecal valve in the case of Indiana Pouch and ileocecal appendix in the case of Mitrofanoff procedure have been of great use for patients with limited economic resources.


REFERENCES

  1. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972;107:458-61.

  2. Bauer S. Neurogenic bladder: etiology and assessment. Pediatr Nephrol 2008;23:541-51.

  3. Mitrofanoff P. Trans-appendicular continent cystostomy in the management of the neurogenic bladder. Chir Pediatr 1980;21:297-305.

  4. Elder J. Neuropathic bladder. En: Behrman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 16th ed. Philadelphia PA: W.B. Saunders. 2000;pp.1807-9.

  5. Neveus T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardization committee of the International Children’s Continence Society. J Urol 2006;176:314–24.

  6. Selzman AA, Elder JS, Mapstone TB. Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord. Urol Clin North Am 1993;20:485-504.

  7. Stöhrer M, Blok B, Castro-Diaz D, et al. The updated EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 2009;56:81-8.

  8. Martínez-Agulló E, Burgués Gasión JP, Alapont Alacreu JM. Vejiga neurogénica: conceptos básicos. Clínicas Urológicas de la Complutense 2000;8:283-347.

  9. Blaivas JG, Appell RA, Fantl JA. Definition and classification of urinary incontinence: recommendations of the Urodynamic Society. Neurourol Urodyn 1997;16:149-51.

  10. van Gool JD, Dik P, de Jong TP. Bladder-sphincter dysfunction in myelomeningocele. Eur J Pediatr 2001;160:414-20.

  11. Bauer SB. Neuropathic dysfunction of the lower urinary tract. En: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell- Walsh Urology. 9th Ed. Philadelphia, PA. Saunders Elsevier, 2006;pp.3625–55.

  12. Flood HD, Ritchey ML, Bloom DA, Huang C, McGuire EJ. Outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring. J Urol 1994;152:1574-7.

  13. Chiaramonte RM, Horowitz EM, Kaplan GW, Brock WA. Implications of hydronephrosis in newborns with myelodysplasia. J Urol 1986;136:427-9.

  14. Bauer SB. Vesico-ureteral reflux in children with neurogenic bladder dysfunction. In: Johnston EH. International Perspectives in Urology, Vol. 10. Baltimore: Williams & Wilkins, 1984;pp.159-165.

  15. Bauer SB. Early evaluation and management of children with spina bifida. In: King LR. Urologic Surgery in Neonates and Young Infants. Philadelphia: WB Saunders 1988;pp.252–64.

  16. Joseph DB, Bauer SB, Colodny AH, et al. Clean intermittent catheterization in infants with neurogenic bladder. Pediatrics. 1989 Jul;84:78-82.

  17. Kasabian NG, Bauer SB, Dyro FM, et al. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 1992;146:840-3.

  18. Kropp B, Cheng E. Bladder augmentation: current and future techniques. En: Kelalis P. Textbook clinical pediatric urology. 5th edition. Informa Healthcare. United Kingdom 2007;pp.871-909.

  19. Reyblat P, Ginsberg DA. Augmentation cystoplasty: what are the indications? Curr Urol Rep 2008;9:452-8.

  20. Rink RC, Hollensbee D, Adams MC. Complications of bladder augmentation in children and comparison of gastrointestinal segments. AUA Update Series 1995;14:122-7.

  21. Gilbert SM, Hensle TW. Metabolic consequences and long-term complications of enterocystoplasty. J Urol 2005;173:1080-6.

  22. Metcalfe PD, Casale AJ, Kaefer MA, et al. Spontaneous bladder perforations: A report of 500 augmentations in children and analysis of risk. J Urol 2006;175:1466-70.

  23. Ring K, Hensle T. Urinary diversion. In: Kelalis P, King LE, Belman AB. Clinical Pediatric Urology. 3rd Ed. Philadelphia PA: WB Saunders. 1992;pp.491-528.




2020     |     www.medigraphic.com